Market Overview:
The global herpes zoster treatment market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of herpes zoster, rising awareness about available treatments, and growing demand for better and more effective therapies. The global herpes zoster treatment market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into oral medications, topical medications, and others (including injections and photodynamic therapy). Oral medications are further sub-segmented into antivirals and analgesics/painkillers. Topical medications are further sub-segmented into creams/ointments and patches. On the basis of application, the market is segmented into hospitals & clinics settingsand home care settings. Geographically,the global herpes zoster treatmentmarketis dividedinto five regions: North America,, Latin America,, Europe,, Asia Pacificand Middle East & Africa).
Product Definition:
Herpes zoster, also known as shingles, is a viral infection that causes a painful rash. The virus that causes herpes zoster is the same one that causes chickenpox.
Oral:
Oral Herpes Zoster (OHZ) or sometimes known as cold sores is a common condition associated with the human body. It is caused by the reactivation of varicella-zoster virus which was previously active in the individual. The virus remains latent in sensory nerve cells of the individual and gets activated when it comes in contact with an external stimulus such as temperature changes, sun exposure, etc.
Topical:
Topical (Oral or Transdermal) is used to treat Herpes Zoster (shingles), a common condition that affects the skin. It is also used for other conditions such as rheumatoid arthritis, ankylosing spondylitis, psoriasis and others. Topical drugs are usually easy to use and have fewer side effects compared to other drugs available in the market.
Application Insights:
Based on application, the global herpes zoster treatment market is segmented into hospitals, clinics and other settings, and home care settings. Hospitals held the largest share in 2017 owing to factors such as a large patient base with high prevalence of HZ infection and availability of advanced healthcare facilities. The hospital segment is anticipated to maintain its dominance throughout the forecast period due to increasing awareness about early diagnosis & treatment among patients suffering from HZD.
The home care setting was one of the fastest-growing segments in 2017 owing to an increase in demand for highly effective but less expensive alternative therapies that do not require medical consultation or presence of a doctor/specialist during its administration. In addition, an increase in incidence rates among older population groups may spur growth over next few years.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of manufacturers and suppliers, favorable reimbursement policies, and increasing prevalence of chronic diseases are some factors attributing to its largest share. Moreover, the availability of products that have passed through clinical trials is expected to drive regional growth over the forecast period.
Asia Pacific is estimated to witness lucrative CAGR during the forecast period owing to an increase in awareness about this disease coupled with growing disposable income especially in emerging countries such as China & India. Furthermore, government initiatives for creating awareness about zoster treatment options will also boost demand for these drugs over the next eight years.
Growth Factors:
- Increasing incidence of herpes zoster
- Growing awareness about the benefits of early treatment
- Rising demand for better and more effective therapies
- Technological advancements in herpes zoster treatment options
- Availability of government funding for research and development
Scope Of The Report
Report Attributes
Report Details
Report Title
Herpes Zoster Treatment Market Research Report
By Type
Oral, Topical, Others
By Application
Hospitals, Clinics, Home Care Settings
By Companies
Roche, Novartis, Merck, GlaxoSmithKline, Abbott Laboratories, Astellas Pharma, Bausch Health Companies, Teva Pharmaceutical, Foamix Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
146
Number of Tables & Figures
103
Customization Available
Yes, the report can be customized as per your need.
Global Herpes Zoster Treatment Market Report Segments:
The global Herpes Zoster Treatment market is segmented on the basis of:
Types
Oral, Topical, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Home Care Settings
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Roche
- Novartis
- Merck
- GlaxoSmithKline
- Abbott Laboratories
- Astellas Pharma
- Bausch Health Companies
- Teva Pharmaceutical
- Foamix Pharmaceuticals
Highlights of The Herpes Zoster Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oral
- Topical
- Others
- By Application:
- Hospitals
- Clinics
- Home Care Settings
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Herpes Zoster Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Herpes zoster (shingles) is a painful, blistering rash that can occur on any part of the body. The rash usually appears as a series of small, red lesions that may spread to other parts of the body. Herpes zoster treatment involves using antiviral medications to reduce the severity and duration of symptoms. In some cases, surgery may also be necessary to remove lesions from around the spinal cord or brain.
Some of the major companies in the herpes zoster treatment market are Roche, Novartis, Merck, GlaxoSmithKline, Abbott Laboratories, Astellas Pharma, Bausch Health Companies, Teva Pharmaceutical, Foamix Pharmaceuticals.
The herpes zoster treatment market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Herpes Zoster Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Herpes Zoster Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Herpes Zoster Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Herpes Zoster Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Herpes Zoster Treatment Market Size & Forecast, 2018-2028
4.5.1 Herpes Zoster Treatment Market Size and Y-o-Y Growth
4.5.2 Herpes Zoster Treatment Market Absolute $ Opportunity
Chapter 5 Global Herpes Zoster Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Herpes Zoster Treatment Market Size Forecast by Type
5.2.1 Oral
5.2.2 Topical
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Herpes Zoster Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Herpes Zoster Treatment Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Home Care Settings
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Herpes Zoster Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Herpes Zoster Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Herpes Zoster Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Herpes Zoster Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Herpes Zoster Treatment Market Size Forecast by Type
9.6.1 Oral
9.6.2 Topical
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Herpes Zoster Treatment Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Home Care Settings
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Herpes Zoster Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Herpes Zoster Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Herpes Zoster Treatment Market Size Forecast by Type
10.6.1 Oral
10.6.2 Topical
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Herpes Zoster Treatment Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Home Care Settings
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Herpes Zoster Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Herpes Zoster Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Herpes Zoster Treatment Market Size Forecast by Type
11.6.1 Oral
11.6.2 Topical
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Herpes Zoster Treatment Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Home Care Settings
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Herpes Zoster Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Herpes Zoster Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Herpes Zoster Treatment Market Size Forecast by Type
12.6.1 Oral
12.6.2 Topical
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Herpes Zoster Treatment Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Home Care Settings
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Herpes Zoster Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Herpes Zoster Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Herpes Zoster Treatment Market Size Forecast by Type
13.6.1 Oral
13.6.2 Topical
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Herpes Zoster Treatment Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Home Care Settings
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Herpes Zoster Treatment Market: Competitive Dashboard
14.2 Global Herpes Zoster Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Roche
14.3.2 Novartis
14.3.3 Merck
14.3.4 GlaxoSmithKline
14.3.5 Abbott Laboratories
14.3.6 Astellas Pharma
14.3.7 Bausch Health Companies
14.3.8 Teva Pharmaceutical
14.3.9 Foamix Pharmaceuticals
